MedPath

Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance

Not Applicable
Completed
Conditions
Sleep Disturbance
Interventions
Behavioral: Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference
Registration Number
NCT04101526
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Brief Summary

The purpose of this study is to learn about how to provide treatment to cancer survivors who have difficulty sleeping.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Located in the Southern Puerto Rico area
  • Able to speak and read Spanish
  • Have no documented or observable disabilities that would interfere with study participation
  • Has completed primary treatment for breast cancer (e.g., surgery, chemotherapy, radiation)
  • Has clinically significant sleep disturbance (i.e., >/= 8 on the Insomnia Severity Index)
  • Is at low risk of other sleep disorders that are not amenable to treatment with cognitive-behavioral therapy
  • Has access to the Internet and a digital device (e.g., smartphone) capable of using videoconference software
Exclusion Criteria
  • Not able to read and speak Spanish

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Videoconference Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I)Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconferenceBehavioral: New Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference
Primary Outcome Measures
NameTimeMethod
Recruitment Rate - Acceptability of New Intervention for Cancer-Related Sleep DisturbancesBaseline

The study will be deemed acceptable if β‰₯ 50% of eligible cancer survivors who are approached agree to participate. Recruitment rate will be measured by percentage of patients enrolled.

Self Report Outcome - Acceptability of New Intervention for Cancer-Related Sleep DisturbancesApproximately 6 weeks after first intervention session

The study will be deemed acceptable if \> 50% of intervention group participants report that, on average, they agree with positive statements about the intervention (i.e., report an average score of \>3 on a scale of 0 to 4).

Number of Participants Attending Educational Component - Feasibility of New Intervention for Cancer-Related Sleep Disturbancesapproximately 6 weeks after first intervention session

The study will be deemed feasible if β‰₯ 75% of the intervention group participants attend at least half of the educational components of the intervention. This will be operationalized as having attended at least half of the sessions.

Secondary Outcome Measures
NameTimeMethod
Efficacy of New Intervention Using PSQI ScoringBaseline and approximately 6 weeks after first intervention session

Pittsburgh Sleep Quality Index (PSQI) Scoring:

Duration of Sleep, Sleep Disturbance, Sleep Latency, Days of Disfunction due to Sleepiness, Sleep Efficiency, Overall Sleep Quality, and Meds Needed to Sleep Response Scale 0 (better) 3 (worse). Total Minimum Score 0 (Better), Total Maximum Score 21 (Worse)

≀ 5 = Good Sleep Quality \>5 = Poor Sleep Quality

Efficacy of New Intervention Using ISI ScoringBaseline and approximately 6 weeks after first intervention session

Insomnia Severity Index (ISI) Scoring:

Sleep Quality, Symptom Severity, Sleep Patterns, Daily Functioning, Insomnia Noticeable to Others, Level of Distress Caused by Insomnia Response Scale 0 (better) 4 (worse) Total Minimum Score 0 (Better) Total Maximum Score 28 (Worse)

0-7: No Clinically Significant Insomnia 8-14: Subthreshold Insomnia 15-21: Clinical Insomnia 22-28: Severe Clinical Insomnia

Trial Locations

Locations (2)

H Lee Moffitt Cancer and Research Institute

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Ponce Health Services University

πŸ‡΅πŸ‡·

Ponce, Puerto Rico

Β© Copyright 2025. All Rights Reserved by MedPath